
Keywords: مهارکننده Farnesyl Transferase; Nucleoskeleton; Envelopathies; Progeria; Myopathy; Neuropathy; Lipodystrophy; Nonalcoholic Fatty Liver Disease; BANF1; barrier to autointegration factor; EDMD; Emery-Dreifuss muscular dystrophy; FTI; farnesyl transferase inhibitor; FPLD2; type 2 (Dunnigan